EverSource Wealth Advisors’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTX
EverSource Wealth Advisors's CNTX Position: Q3 2026 in Review
EverSource Wealth Advisors opened a new position in Context Therapeutics (CNTX) in Q3 2026: 716 shares worth $215. The stake represents ﹤0.01% of the portfolio and ranks #4316 among its holdings.
85 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.
- EverSource Wealth Advisors held 716 shares of Context Therapeutics worth $215 as of Q3 2026.
- Context Therapeutics was a new EverSource Wealth Advisors position in Q3 2026.
- Context Therapeutics made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4316 holding.
- 85 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.
Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.